{"id":1306347,"date":"2026-02-19T11:31:00","date_gmt":"2026-02-19T06:01:00","guid":{"rendered":"https:\/\/trak.in\/stories\/?p=1306347"},"modified":"2026-02-19T11:42:23","modified_gmt":"2026-02-19T06:12:23","slug":"dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india","status":"publish","type":"post","link":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/","title":{"rendered":"Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India"},"content":{"rendered":"\n<p>Indian pharmaceutical giant <strong>Dr Reddy&#8217;s Laboratories<\/strong> is gearing up to introduce a <strong>generic and significantly cheaper version of Novo Nordisk\u2019s blockbuster weight-loss drug Wegovy<\/strong>. The company\u2019s move could sharply reduce the cost of obesity treatment in India and globally, tapping into a market that analysts expect to be worth tens of billions of dollars annually.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"554\" src=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-1024x554.png\" alt=\"\" class=\"wp-image-1306386\" srcset=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-1024x554.png 1024w, https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-300x162.png 300w, https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-768x416.png 768w, https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-1536x832.png 1536w, https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-2048x1109.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Affordable Alternative to an Expensive Treatment<\/strong><\/h3>\n\n\n\n<p>Wegovy, based on the molecule <em>semaglutide<\/em>, has become one of the most prescribed obesity medications worldwide. In India, its monthly cost ranges from about \u20b910,850 for the lowest dose to \u20b916,400 for the highest. These prices put the drug out of reach for many patients despite rising obesity rates.<\/p>\n\n\n\n<p>Dr. Reddy\u2019s co-chairman and MD, <strong>G V Prasad<\/strong>, told Reuters at the BioAsia conference in Hyderabad that the company aims to price its generic version <strong>up to 60 % lower<\/strong> than the branded Wegovy, making it a far more affordable option. He said that a discount in the range of <strong>50 %\u201360 % compared to the original is feasible<\/strong> \u2014 a substantial reduction that could widen access to treatment.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Patent Expiry Spurs Generic Competition<\/strong><\/h3>\n\n\n\n<p>The opportunity arises because the <strong>patent on semaglutide is set to expire in March 2026<\/strong>, opening the door for generic manufacturers like Dr. Reddy\u2019s to produce and sell less costly versions. Last month, the company received regulatory approval in India to manufacture and market a generic of <em>Ozempic<\/em>, another semaglutide-based product used for diabetes, and is now waiting for final approval on its Wegovy equivalent.<\/p>\n\n\n\n<p>Dr. Reddy\u2019s has sufficient manufacturing capacity and plans to <strong>work with local partners<\/strong> to meet demand. The company aims to sell <strong>about 12 million injectable semaglutide pens in the first year<\/strong> after launch. Prasad noted that several generic manufacturers are expected to enter the market, and competition will determine who captures the largest share.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Boost for Treatment Access and Industry Competition<\/strong><\/h3>\n\n\n\n<p>This strategy positions Dr. Reddy\u2019s at the forefront of a growing global race to produce affordable versions of expensive obesity treatments. As obesity becomes an increasing public health challenge in India and worldwide, cheaper generics could help more patients access effective therapy while also reshaping the market dynamics previously dominated by expensive branded drugs.<\/p>\n\n\n\n<p><a href=\"https:\/\/edition.cnn.com\/2024\/05\/02\/health\/wegovy-weight-loss-drug-new-prescriptions\">Image Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indian pharmaceutical giant Dr Reddy&#8217;s Laboratories is gearing up to introduce a generic and significantly cheaper version of Novo Nordisk\u2019s blockbuster weight-loss drug Wegovy. The company\u2019s move could sharply reduce the cost of obesity treatment in India and globally, tapping into a market that analysts expect to be worth tens of billions of dollars annually. [&hellip;]<\/p>\n","protected":false},"author":30,"featured_media":1306386,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[8137],"class_list":["post-1306347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-wegovy"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India - Trak.in - Indian Business of Tech, Mobile &amp; Startups<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India - Trak.in - Indian Business of Tech, Mobile &amp; Startups\" \/>\n<meta property=\"og:description\" content=\"Indian pharmaceutical giant Dr Reddy&#8217;s Laboratories is gearing up to introduce a generic and significantly cheaper version of Novo Nordisk\u2019s blockbuster weight-loss drug Wegovy. The company\u2019s move could sharply reduce the cost of obesity treatment in India and globally, tapping into a market that analysts expect to be worth tens of billions of dollars annually. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/\" \/>\n<meta property=\"og:site_name\" content=\"Trak.in - Indian Business of Tech, Mobile &amp; Startups\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-19T06:01:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-19T06:12:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-1024x554.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"554\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mohul Ghosh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mohul Ghosh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/\",\"url\":\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/\",\"name\":\"Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India - Trak.in - Indian Business of Tech, Mobile &amp; Startups\",\"isPartOf\":{\"@id\":\"https:\/\/trak.in\/stories\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-scaled.png\",\"datePublished\":\"2026-02-19T06:01:00+00:00\",\"dateModified\":\"2026-02-19T06:12:23+00:00\",\"author\":{\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7\"},\"breadcrumb\":{\"@id\":\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#primaryimage\",\"url\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-scaled.png\",\"contentUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-scaled.png\",\"width\":2560,\"height\":1386},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/trak.in\/stories\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/trak.in\/stories\/#website\",\"url\":\"https:\/\/trak.in\/stories\/\",\"name\":\"Trak.in - Indian Business of Tech, Mobile &amp; Startups\",\"description\":\"Trak.in is a popular Indian Business, Technology, Mobile &amp; Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups &amp; Social Media Space\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/trak.in\/stories\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7\",\"name\":\"Mohul Ghosh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g\",\"caption\":\"Mohul Ghosh\"},\"url\":\"https:\/\/trak.in\/stories\/author\/mohul-ghosh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India - Trak.in - Indian Business of Tech, Mobile &amp; Startups","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/","og_locale":"en_US","og_type":"article","og_title":"Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India - Trak.in - Indian Business of Tech, Mobile &amp; Startups","og_description":"Indian pharmaceutical giant Dr Reddy&#8217;s Laboratories is gearing up to introduce a generic and significantly cheaper version of Novo Nordisk\u2019s blockbuster weight-loss drug Wegovy. The company\u2019s move could sharply reduce the cost of obesity treatment in India and globally, tapping into a market that analysts expect to be worth tens of billions of dollars annually. [&hellip;]","og_url":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/","og_site_name":"Trak.in - Indian Business of Tech, Mobile &amp; Startups","article_published_time":"2026-02-19T06:01:00+00:00","article_modified_time":"2026-02-19T06:12:23+00:00","og_image":[{"width":1024,"height":554,"url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-1024x554.png","type":"image\/png"}],"author":"Mohul Ghosh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mohul Ghosh","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/","url":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/","name":"Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India - Trak.in - Indian Business of Tech, Mobile &amp; Startups","isPartOf":{"@id":"https:\/\/trak.in\/stories\/#website"},"primaryImageOfPage":{"@id":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#primaryimage"},"image":{"@id":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#primaryimage"},"thumbnailUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-scaled.png","datePublished":"2026-02-19T06:01:00+00:00","dateModified":"2026-02-19T06:12:23+00:00","author":{"@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7"},"breadcrumb":{"@id":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#primaryimage","url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-scaled.png","contentUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-scaled.png","width":2560,"height":1386},{"@type":"BreadcrumbList","@id":"https:\/\/trak.in\/stories\/dr-reddy-will-sell-viral-diabetes-drug-ozempic-at-60-discount-in-india\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/trak.in\/stories\/"},{"@type":"ListItem","position":2,"name":"Dr Reddy Will Sell Viral Weight Loss Drug Wegovy At 60% Discount In India"}]},{"@type":"WebSite","@id":"https:\/\/trak.in\/stories\/#website","url":"https:\/\/trak.in\/stories\/","name":"Trak.in - Indian Business of Tech, Mobile &amp; Startups","description":"Trak.in is a popular Indian Business, Technology, Mobile &amp; Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups &amp; Social Media Space","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/trak.in\/stories\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7","name":"Mohul Ghosh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g","caption":"Mohul Ghosh"},"url":"https:\/\/trak.in\/stories\/author\/mohul-ghosh\/"}]}},"jetpack_featured_media_url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-19-at-11.40.04-AM-scaled.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1306347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/comments?post=1306347"}],"version-history":[{"count":3,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1306347\/revisions"}],"predecessor-version":[{"id":1306387,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1306347\/revisions\/1306387"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media\/1306386"}],"wp:attachment":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media?parent=1306347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/categories?post=1306347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/tags?post=1306347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}